Addiction Medicine Updates

ATLANTA (AP) — Georgia soon will become the first state in the nation to offer medical marijuana products at independent pharmacies, state officials said. The Georgia Board of Pharmacy began accepting applications this week, and nearly 120 pharmacies have agreed to provide medication from Botanical Sciences, one of the state’s two licensed production companies, The Atlanta...

Synopsis: The importance of responsibly expanding access to methadone treatment for opioid use disorder (OUD) is crucial. Methadone, a long-lasting opioid agonist, is a well-studied and effective medical treatment for OUD, which is associated with a significantly higher risk of early death. While there is support for liberalizing access to methadone from opioid treatment programs...

Dear Registrants: On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA Waiver Program.” DEA fully supports this significant policy reform. ln this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing...

— But now, doctors will have to take substance use disorder training to get their DEA license by Amanda D’Ambrosio, Enterprise & Investigative Writer, MedPage, January 5, 2023 The Biden administration’s recent spending billopens in a new tab or window contained under-the-radar changes for addiction medicine, including eliminating the X waiver requirement for clinicians...

Dear Colleague, The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Division of Grant Review is recruiting new Peer Reviewers for our funding opportunities in mental health services and substance abuse prevention and treatment. Our Peer Reviewers evaluate grant applications through a fair, equitable and objective review process to provide SAMHSA and grant...

Public Policy Statement on the Regulation of the Treatment of Opioid Use Disorder with Methadone Excerpt: The treatment of opioid use disorder (OUD) with methadone has a long history and robust scientific evidence supporting its effectiveness. Currently, U.S. federal law limits its availability to certified, accredited, and heavily regulated opioid treatment programs (OTPs), a...

The Substance Abuse and Mental Health Services Administration (SAMHSA) proposed new rules to expand access to treatment for opioid use disorder (OUD), in particular with methadone through opioid treatment programs (OTPs). The proposed changes will provide greater autonomy to OTP practitioners, as well as expand on telehealth and take-home flexibilities initially granted in connection...

We are sharing the information below on behalf of our colleagues at the Tennessee Department of Mental Health and Substance Abuse Services. International Overdose Awareness Day is coming up August 31. To mark the date, the State of Tennessee and its community partners are holding trainings on overdose reversal. The medication known as naloxone (brand name Narcan) is an easy-to-use overdose...

Georgia will be 1st state to allow pharmacies to sell medical marijuana

The Modernizing Opioid Treatment Access Act: A Helpful Explanation

Bye-bye X-Waiver

The X Waiver Is Officially Dead

SAMSHSA Recruiting Peer Reviewers for Funding Opportunities

ASAM’s Public Policy Statement on Regulation of Opioid Use Disorder Treatment

SAMHSA Proposes New Rules to Expand Access to Treatment

International Overdose Awareness Day

The Georgia Society of Addiction Medicine